Schrödinger, Inc. (SDGR)
NASDAQ: SDGR · Real-Time Price · USD
29.53
-1.32 (-4.28%)
At close: Nov 13, 2026, 4:00 PM EST
29.84
+0.31 (1.05%)
After-hours: Nov 13, 2026, 7:30 PM EST

Schrödinger Revenue

Schrödinger had revenue of $64.49M in the quarter ending September 30, 2026, with 18.72% growth. This brings the company's total for the last twelve months to $269.20M, up 4.77% year-over-year. In the year 2025, Schrödinger had annual revenue of $255.87M with 23.29% growth. That makes Schrödinger the 15,333rd largest company in the world by revenue and 2,684th in the United States.

Revenue (ttm)
$269.20M
Revenue Growth
+4.77%
P/S Ratio
8.24
Revenue / Employee
$316,708
Employees
850
Market Cap
2.22B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Software 199.50M 78.0%
  • Drug Discovery 56.37M 22.0%

By Geography

Chart
  • United States 152.96M 59.8%
  • Emea 75.16M 29.4%
  • Apac 26.18M 10.2%
  • Rest of World 1.56M 0.6%
Fiscal year ended Dec 31, 2025 See the full Schrödinger breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025255.87M48.33M23.29%
Dec 31, 2024207.54M-9.13M-4.21%
Dec 31, 2023216.67M35.71M19.73%
Dec 31, 2022180.96M43.02M31.19%
Dec 31, 2021137.93M29.84M27.60%
Dec 31, 2020108.10M22.55M26.36%
Dec 31, 201985.54M18.90M28.37%
Dec 31, 201866.64M10.95M19.65%
Dec 31, 201755.69M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Teladoc Health2.47B
Privia Health Group2.43B
Waystar Holding1.26B
Omnicell1.24B
GoodRx Holdings785.23M
Doximity661.58M
Phreesia507.79M
Certara425.76M
Revenue Rankings